Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Lacquer

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44335   clinical trials with a EudraCT protocol, of which   7366   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    23 result(s) found for: Lacquer. Displaying page 1 of 2.
    1  2  Next»
    EudraCT Number: 2006-006569-18 Sponsor Protocol Number: V00074 VE 202 04A Start Date*: 2007-03-16
    Sponsor Name:PIERRE FABRE DERMATOLOGIE represented by INSTITUT DE RECHERCHE PIERRE FABRE
    Full Title: EFFICACY AND SAFETY OF 8% CLOBETASOL NAIL LACQUER FORMULATION VERSUS VEHICLE IN NAIL PSORIASIS
    Medical condition: NAIL PSORIASIS
    Disease: Version SOC Term Classification Code Term Level
    9.1 10028703 Nail psoriasis PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FR (Completed)
    Trial results: View results
    EudraCT Number: 2013-000544-26 Sponsor Protocol Number: RD.03.SPR.29106 Start Date*: 2013-12-10
    Sponsor Name:Galderma R&D
    Full Title: Determination of antifungal activity of Loceryl® Nail Lacquer 5% when used concomitantly with a cosmetic nail varnish compared to a Loceryl® Nail Lacquer 5% alone in treatment of toenail Distal Sub...
    Medical condition: Mild to moderate toenail Distal Subungual Onychomycosis
    Disease: Version SOC Term Classification Code Term Level
    14.1 10021881 - Infections and infestations 10030338 Onychomycosis PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IS (Completed)
    Trial results: View results
    EudraCT Number: 2011-003087-70 Sponsor Protocol Number: PM1125 Start Date*: 2011-12-02
    Sponsor Name:Polichem SA
    Full Title: Randomized, open-label, controlled study on the efficacy of Ciclopoli® (ciclopirox 8% nail lacquer) versus Loceryl® (amorolfine 5% nail lacquer) on the culture conversion to negative in patients w...
    Medical condition: distal subungual onychomycosis without lunula involvement due to fungal nail pathogens (dermatophytes, white yeasts and/or Scopulariopsis spp. and/or Fusarium spp.) affecting at least one big toenail
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: LV (Completed)
    Trial results: View results
    EudraCT Number: 2015-001237-24 Sponsor Protocol Number: RD.03.SPR.105082 Start Date*: 2015-07-28
    Sponsor Name:Galderma R&D
    Full Title: Subject adherence and satisfaction for treatment of Onychomycosis with Loceryl® Nail Lacquer 5% versus Ciclopoli® Nail Lacquer.
    Medical condition: Toenail Distal and Lateral Subungual Onychomycosis
    Disease: Version SOC Term Classification Code Term Level
    18.0 10021881 - Infections and infestations 10030338 Onychomycosis PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2006-005895-42 Sponsor Protocol Number: TLT-CLI-001 Start Date*: 2009-03-02
    Sponsor Name:TLT Medical Ltd.
    Full Title: A study to determine the safety and efficacy of a terbinafine topical formulation system in subjects with onychomycosis in laser treated toenails versus ciclopirox lacquer in intact toenails
    Medical condition: Distal/lateral Subungual onychomycosis (DSO) caused by dermatophytes
    Disease: Version SOC Term Classification Code Term Level
    8.1 10030338 Onychomycosis LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IS (Completed)
    Trial results: (No results available)
    EudraCT Number: 2006-000974-54 Sponsor Protocol Number: RD.03.SPR.40026 Start Date*: 2007-02-28
    Sponsor Name:GALDERMA Research & Development
    Full Title: A multi-centre, randomized, parallel groups, vehicle and active controlled study of amorolfine 4% and 10% nail lacquer new formulation in the topical treatment of distal and lateral subungual toena...
    Medical condition: Distal and lateral subungual onychomycosis
    Disease: Version SOC Term Classification Code Term Level
    8.1 10030338 LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: IS (Completed) CZ (Completed) DE (Completed)
    Trial results: View results
    EudraCT Number: 2004-004825-87 Sponsor Protocol Number: R00002 VE 201 Start Date*: 2005-04-22
    Sponsor Name:Pierre Fabre Dermatologie represented by Institut de Recherche Pierre Fabre
    Full Title: Efficacy and safety of 0,1%, 0,5% and 1% TAZAROTENE nail lacquer formulation versus vehicle in nail psoriasis. International, multicenter, double-blind, randomized study of four parallel groups.
    Medical condition: Psoriasis of the skin is frequently accompanied by nail changes: between 10 and 78% of psoriatic patients suffer from changes of the nails. More than 50% of patients with nail psoriasis have pain b...
    Disease: Version SOC Term Classification Code Term Level
    7.1 10028703 PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: HU (Completed) DE (Completed) CZ (Completed)
    Trial results: View results
    EudraCT Number: 2015-001503-31 Sponsor Protocol Number: RD.03.SPR.105078 Start Date*: 2015-11-30
    Sponsor Name:Galderma R&D
    Full Title: Subject adherence and satisfaction for treatment of Onychomycosis with Loceryl® Nail Lacquer 5% versus Canesten® Fungal Nail Treatment Set
    Medical condition: Mycological confirmed toenail Distal and Lateral Subungual Onychomycosis
    Disease: Version SOC Term Classification Code Term Level
    18.1 10021881 - Infections and infestations 10030338 Onychomycosis PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IS (Completed)
    Trial results: View results
    EudraCT Number: 2009-017642-32 Sponsor Protocol Number: Nyreprofylakse1 Start Date*: 2010-02-16
    Sponsor Name:Odense University Hospital
    Full Title: Nyreprofylakse ved ST-segment elevation myokardie infarkt og primær PCI
    Medical condition: Decreased renal function in patients with STEMI undergoing acute PCI
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DK (Completed)
    Trial results: View results
    EudraCT Number: 2006-003570-10 Sponsor Protocol Number: CSFO327N2303 Start Date*: 2007-03-02
    Sponsor Name:Novartis Pharma Services AG
    Full Title: A randomized, open-label, active-controlled, multicenter, parallel group study to assess the efficacy, safety and tolerability of topical 10% terbinafine hydrogen chloride (HCl) formulation versus ...
    Medical condition: mild to moderate toenail onychomycosis
    Disease: Version SOC Term Classification Code Term Level
    8.1 10030338 Onychomycosis LLT
    Population Age: Adolescents, Under 18, Adults, Elderly Gender: Male, Female
    Trial protocol: IS (Completed) FI (Completed) HU (Completed) ES (Completed) FR (Completed) DE (Completed)
    Trial results: View results
    EudraCT Number: 2016-003784-19 Sponsor Protocol Number: RJ-CPX01 Start Date*: 2017-07-21
    Sponsor Name:Laboratorio Reig Jofre, SA
    Full Title: Phase III, multicentre, randomised, double blind, parallel-group, clinical trial to evaluate the efficacy and safety of a new medicated nail lacquer for the treatment of toenail fungal infection
    Medical condition: toenail onychomycosis
    Disease: Version SOC Term Classification Code Term Level
    19.1 10021881 - Infections and infestations 10030338 Onychomycosis PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: ES (Completed) LV (Completed)
    Trial results: View results
    EudraCT Number: 2022-003913-12 Sponsor Protocol Number: 22/589-EC_M. Start Date*: 2023-03-07
    Sponsor Name:COMPLUTENSE UNIVERSITY OF MADRID
    Full Title: Diode laser and photodynamic therapy Versus Ciclopirox Hydroxypropyl Chitosan. Randomised controlled clinical trial.
    Medical condition: Onychomycosis
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: ES (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2009-011125-14 Sponsor Protocol Number: RV4104A-2008-548 Start Date*: 2009-07-06
    Sponsor Name:Pierre Fabre Dermatologie
    Full Title: A multicentre, randomized, controlled study of the efficacy, safety and cost-effectiveness of a sequential therapy with RV4104A ointment, ciclopiroxolamine cream and ciclopirox film-forming solutio...
    Medical condition: Patients suffering from distal-lateral or lateral subungual onychomycosis of one great toenail (the target nail) without matrix involvement
    Disease: Version SOC Term Classification Code Term Level
    9.1 10030338 Onychomycosis LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FR (Completed)
    Trial results: View results
    EudraCT Number: 2008-002707-10 Sponsor Protocol Number: PM0731 Start Date*: 2009-03-04
    Sponsor Name:Polichem SA
    Full Title: MULTICENTRE, RANDOMIZED, DOUBLE BLIND WITHIN FREQUENCY OF ADMINISTRATION, PLACEBO CONTROLLED, DOSE-FINDING, PARALLEL-GROUP, EFFICACY AND SAFETY STUDY OF 3 DOSES OF P-3058 NAIL LACQUER (5% o.d., 10%...
    Medical condition: Mild to moderate distal subungual Onychomycosis due to Dermatophytes.
    Disease: Version SOC Term Classification Code Term Level
    14.1 10021881 - Infections and infestations 10030338 Onychomycosis PT
    Population Age: Adolescents, Under 18, Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed) CZ (Completed) LV (Completed) IT (Completed) FR (Completed) PL (Completed)
    Trial results: View results
    EudraCT Number: 2015-000561-31 Sponsor Protocol Number: PM1331 Start Date*: 2015-06-15
    Sponsor Name:Polichem S.A.
    Full Title: A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PARALLEL, VEHICLE-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF P-3058 10% NAIL SOLUTION IN THE TREATMENT OF ONYCHOMYCOSIS
    Medical condition: Mild to moderate distal subungual Onychomycosis caused by Dermatophytes
    Disease: Version SOC Term Classification Code Term Level
    19.0 10021881 - Infections and infestations 10030338 Onychomycosis PT
    Population Age: Adolescents, Under 18, Adults, Elderly Gender: Male, Female
    Trial protocol: HU (Completed) LV (Completed) BG (Completed) SE (Completed) DE (Completed) SK (Completed) BE (Completed) PL (Completed) CZ (Completed) LT (Completed) GR (Completed) IS (Completed)
    Trial results: View results
    EudraCT Number: 2007-004331-27 Sponsor Protocol Number: P05205 Start Date*: 2008-12-23
    Sponsor Name:Schering-Plough Research Institute, a Division of Schering Corporation
    Full Title: A Randomized, Double-Blind, Vehicle-Controlled, Multicenter Study to Evaluate the Safety and Efficacy of SCH 900340 5% Solution Compared with Vehicle Administered Topically in the Treatment of Dist...
    Medical condition: Onychomycosis
    Disease: Version SOC Term Classification Code Term Level
    9.1 10030338 Onychomycosis LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Prematurely Ended) IS (Prematurely Ended) BE (Completed) SE (Prematurely Ended) ES (Prematurely Ended) GB (Prematurely Ended) BG (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2013-003334-33 Sponsor Protocol Number: CRFB002FIT01 Start Date*: 2013-12-16
    Sponsor Name:NOVARTIS FARMA
    Full Title: A 12-month, open-label, interventional, multicentre study to investigate the current criteria driving re-treatment with ranibizumab upon relapse in patients with visual impairment due to choroidal ...
    Medical condition: Choroidal neovascularization secondary to pathologic myopia
    Disease: Version SOC Term Classification Code Term Level
    14.1 100000004853 10060837 Choroidal neovascularization LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Completed)
    Trial results: View results
    EudraCT Number: 2008-002427-90 Sponsor Protocol Number: SD-AMO-00326-08 Start Date*: 2008-10-20
    Sponsor Name:SUBSTIPHARM Développement
    Full Title: Etude en double aveugle de l’équivalence clinique et mycologique du Locéryl® (Amorolfine, solution filmogène à 5%) et de son générique dans le traitement des onychomycoses sans atteinte de la matr...
    Medical condition: Tout patient présentant une onychomycose unguéale sans atteinte matricielle d’un doigt ou d’un orteil n’ayant jamais encore été traité par un antimycosique
    Disease: Version SOC Term Classification Code Term Level
    9.1 10030338 Onychomycosis PT
    Population Age: Adults Gender: Male, Female
    Trial protocol: FR (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2010-021662-30 Sponsor Protocol Number: CRFB002F2301 Start Date*: 2010-11-05
    Sponsor Name:Novartis Pharma Services AG
    Full Title: A 12 month, phase III, randomized, double-masked, multi-center, active-controlled study to evaluate the efficacy and safety of two different dosing regimens of 0.5 mg ranibizumab vs. verteporfin PD...
    Medical condition: visual impairment due to choroidal neovascularization secondary to pathologic myopia
    Disease: Version SOC Term Classification Code Term Level
    12.1 10036803 Progressive high (degenerative) myopia LLT
    12.1 10060837 Choroidal neovascularization LLT
    12.1 10047571 Visual impairment LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: PT (Completed) LV (Completed) HU (Completed) LT (Completed) FR (Completed) ES (Completed) IT (Completed) AT (Completed) SK (Completed) DE (Completed) GB (Completed)
    Trial results: View results
    EudraCT Number: 2015-002365-34 Sponsor Protocol Number: PM1434 Start Date*: 2015-10-08
    Sponsor Name:Polichem S.A.
    Full Title: A RANDOMIZED, DOUBLE-BLIND, VEHICLE-CONTROLLED, PARALLEL-GROUP TRIAL TO ASSESS THE EFFICACY, SAFETY AND TOLERABILITY OF P-3073 FOR TOPICAL TREATMENT OF NAIL PSORIASIS
    Medical condition: Mild to moderate psoriatic fingernail/s
    Disease: Version SOC Term Classification Code Term Level
    18.0 10040785 - Skin and subcutaneous tissue disorders 10028703 Nail psoriasis PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: LV (Completed) DE (Completed) CZ (Completed) PL (Completed) BG (Completed) GR (Completed)
    Trial results: View results
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    1  2  Next»
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Wed May 14 15:20:52 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA